PPCBPropanc Biopharma, Inc.vs its industry peers
A metric-by-metric comparison of Propanc Biopharma, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PPCBThis | $12M#8 | — | 1.3x#7 | — | — | 68.0%#1 | — | -200.6%#7 | -176.3%#2 | — | -99.4%#6 | — |
| ADIL | $13M#1 | — | — | — | — | 39.5%#5 | — | — | — | — | -46.7%#2 | — |
| RKTO | $13M#2 | — | 1.6x#8 | — | — | -52.3%#8 | — | -152.0%#5 | — | — | -63.7%#3 | — |
| BFRI | $13M#3 | — | 2.1x#9 | 0.3x#1 | 11.7%#4 | 40.7%#4 | -27.2%#1 | -176.9%#6 | -712.4%#4 | — | -20.4%#1 | — |
| KAPA | $13M#4 | — | 3.0x#11 | — | — | -109.3%#10 | — | -130.0%#4 | — | — | — | — |
| BOLT | $13M#5 | — | 1.0x#5 | 1.6x#2 | 0.1%#5 | 47.1%#3 | -469.3%#2 | -264.1%#11 | — | — | — | — |
| KTTA | $12M#6 | — | 0.2x#1 | 25.4x#6 | 3130.4%#2 | -46.9%#7 | -4286.7%#7 | -41.0%#1 | — | — | — | — |
| HIND | $12M#7 | 0.0x#1 | 4.9x#12 | 38.6x#7 | 24.4%#3 | -609.0%#12 | -3269.4%#6 | -405.7%#12 | -226.2%#3 | — | -68.6%#4 | — |
| VBIO | $12M#9 | — | 2.7x#10 | 14.9x#5 | -33.7%#6 | -57.0%#9 | -1012.6%#4 | -209.1%#9 | — | — | -99.2%#5 | — |
| LPCN | $12M#10 | — | 0.5x#3 | 5.9x#3 | -82.3%#7 | -96400.0%#14 | -524.7%#3 | -44.2%#2 | -52.6%#1 | — | — | — |
| CLRB | $11M#11 | — | 0.4x#2 | — | — | 51.1%#2 | — | -72.9%#3 | — | — | — | — |
| ASBP | $11M#12 | 0.0x#2 | 1.0x#4 | 1834.0x#8 | — | -1768.9%#13 | -312016.9%#8 | -208.2%#8 | — | — | — | — |
| BIVI | $11M#13 | — | 1.0x#6 | — | — | -25.8%#6 | — | -214.9%#10 | -1671.2%#5 | — | — | — |
| DARE | $11M#14 | — | — | 10.3x#4 | 10429.4%#1 | -230.9%#11 | -1315.5%#5 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice